Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-24-046454
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:14
Documents
1
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A ef20038543_sc13ga.htm SC 13G/A 89296
  Complete submission text file 0001140361-24-046454.txt   91048
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Subject) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92449 | Film No.: 241454002
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)